Middle East Pharmaceutical Outlook Report 2025\u20132026<\/p>\n
Published by: Pharmex Middle East (Aland Institute)<\/p>\n
Region Covered: Middle East, North Africa, CIS, South Asia<\/p>\n
The Middle East pharmaceutical sector is entering a period of accelerated transformation driven by population growth, increasing healthcare expenditure, government localization programs, and rising demand for Active Pharmaceutical Ingredients (APIs), machinery, and advanced manufacturing technologies.<\/p>\n
Between 2024\u20132028, the pharmaceutical market in the Middle East is expected to grow at 8\u201312% CAGR, with Iran, Saudi Arabia, Egypt, the UAE, and Turkey forming the core of regional production and consumption.<\/p>\n
1. Middle East Pharmaceutical Market \u2013 Regional Overview<\/p>\n
\ud83d\udd38Market Size<\/p>\n
Middle East pharma market value (2024): ~USD 42 billion
\nSource: IQVIA Middle East Market Report 2024<\/p>\n
Projected market size (2028): ~USD 60 billion<\/p>\n
\ud83d\udd38Key Drivers<\/p>\n
Population across region: ~410 million<\/p>\n
Strong demand for chronic disease treatments<\/p>\n
Expansion of insurance coverage and state healthcare<\/p>\n
API shortages leading to localization programs<\/p>\n
Increased regulatory convergence (Saudi FDA, Iran IFDA, UAE MOH)<\/p>\n
Top Markets in Production Capacity<\/p>\n
1. Turkey \u2013 Finished dosage forms<\/p>\n
2. Iran \u2013 APIs, biosimilars, and raw materials<\/p>\n
3. Saudi Arabia \u2013 Localization programs (Vision 2030)<\/p>\n
4. Egypt \u2013 Large consumer market<\/p>\n
5. UAE \u2013 Regional logistics hub<\/p>\n
2. API & Pharmaceutical Raw Materials Outlook<\/p>\n
\ud83d\udd38Global Context<\/p>\n
The API market is dominated by:<\/p>\n
India (32% global share)<\/p>\n
China (28% global share)
\nSource: UNIDO API Industrial Assessment 2023<\/p>\n
However, due to supply-chain disruptions (COVID, trade barriers, rising costs in India\/China), Middle Eastern governments are aggressively investing in API localization.<\/p>\n
Regional API Demand<\/p>\n
Total API demand in Middle East (2024): USD 6.2 billion<\/p>\n
Expected by 2028: USD 8.7 billion
\nSource: PharmaBoardroom MENA Market Insights 2024<\/p>\n
\ud83d\udd39Iran\u2019s Role<\/p>\n
Iran stands out as:<\/p>\n
The largest producer of pharmaceutical APIs in the Middle East, with:<\/p>\n
Over 70 API-producing companies<\/p>\n
Export partners including India, Russia, Algeria, Iraq, Syria, Pakistan, Afghanestan<\/p>\n
Strong competitive advantage in narcotic APIs and niche intermediates<\/p>\n
3. Pharmaceutical Machinery & Technology Trends<\/p>\n
Machinery and technology adoption in the region is driven by:<\/p>\n
\ud83d\udd38Key Trends<\/p>\n
Automation & digital GMP systems<\/p>\n
Cleanroom technologies<\/p>\n
High-containment systems<\/p>\n
Advanced granulation and continuous manufacturing<\/p>\n
Sterile and oncology production technologies<\/p>\n
\ud83d\udd38Regional Market Size<\/p>\n
Pharma machinery market (Middle East): USD 2.1B
\nSource: Global Process Equipment Outlook 2024<\/p>\n
India, China, Germany, Italy, and Japan are the major suppliers.<\/p>\n
4. Technology Transfer & Investment Opportunities<\/p>\n
Areas of High Demand in the Region<\/p>\n
Oncology APIs<\/p>\n
High-potent drugs (HPAPI)<\/p>\n
Peptides<\/p>\n
Hormonal APIs<\/p>\n
Sterile injectables<\/p>\n
Packaging modernization (track & trace, smart packaging)<\/p>\n
Why the Region Is Attractive for Partnerships<\/p>\n
Growing regional market<\/p>\n
Increasing regulatory harmonization<\/p>\n
Lower production costs compared to EU<\/p>\n
Strong government incentives (Saudi Arabia, Iran, UAE)<\/p>\n
5. Pharmex Middle East \u2013 The Specialized Hub of the Region<\/p>\n
\ud83d\udfe3Why Pharmex Matters<\/strong><\/p>\n Pharmex Middle East is currently the only fully specialized API & machinery exhibition in the region, unlike broader healthcare expos in UAE, Turkey, and Saudi Arabia.<\/p>\n Core Focus of Pharmex<\/p>\n APIs & intermediates<\/p>\n Pharmaceutical machinery & production lines<\/p>\n Packaging solutions<\/p>\n Technology transfer<\/p>\n R&D & formulation technologies<\/p>\n Raw materials and excipients<\/p>\n Participation Statistics (2024\u20132025)<\/p>\n 530+ exhibitors<\/p>\n 20,000+ professional visitors from 20+ countries<\/p>\n Delegations from:<\/p>\n India<\/p>\n Russia<\/p>\n Uzbekistan<\/p>\n Algeria<\/p>\n China<\/p>\n Oman<\/p>\n Pakistan<\/p>\n Iraq<\/p>\n Afghanestan<\/p>\n Cuba<\/p>\n Turkey<\/p>\n Tajikestan<\/p>\n Several African markets and…<\/p>\n International Recognition<\/strong><\/p>\n Listed by JETRO Japan as one of the recommended pharmaceutical exhibitions in the Middle East<\/p>\n","protected":false},"excerpt":{"rendered":" Middle East Pharmaceutical Outlook Report 2025\u20132026 Published by: Pharmex Middle East (Aland Institute) Region Covered: Middle East, North Africa, CIS, South Asia The Middle East pharmaceutical sector is entering a period of accelerated transformation driven by population growth, increasing healthcare expenditure, government localization programs, and rising demand for Active Pharmaceutical Ingredients (APIs), machinery, and advanced […]<\/p>\n","protected":false},"author":1,"featured_media":2847,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":["post-2846","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/aland-market.com\/en\/wp-json\/wp\/v2\/posts\/2846","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/aland-market.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/aland-market.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/aland-market.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/aland-market.com\/en\/wp-json\/wp\/v2\/comments?post=2846"}],"version-history":[{"count":3,"href":"https:\/\/aland-market.com\/en\/wp-json\/wp\/v2\/posts\/2846\/revisions"}],"predecessor-version":[{"id":3104,"href":"https:\/\/aland-market.com\/en\/wp-json\/wp\/v2\/posts\/2846\/revisions\/3104"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/aland-market.com\/en\/wp-json\/wp\/v2\/media\/2847"}],"wp:attachment":[{"href":"https:\/\/aland-market.com\/en\/wp-json\/wp\/v2\/media?parent=2846"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/aland-market.com\/en\/wp-json\/wp\/v2\/categories?post=2846"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/aland-market.com\/en\/wp-json\/wp\/v2\/tags?post=2846"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}